文献速递头颈USPETCT

实时超声图像融合FDG-PET/CT引导颈部淋巴结细针穿刺:可行性与诊断价值

Real-Time Ultrasound Image Fusion with FDG-PET/CT to Perform Fused Image-Guided Fine-Needle Aspiration in Neck Nodes: Feasibility and Diagnostic Value.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-01-28

前瞻性纳入96例颈部淋巴结分期患者,先行常规超声引导细针穿刺,再对FDG-PET阳性淋巴结行实时超声与FDG-PET/CT图像融合引导穿刺。201个PET阳性淋巴结中195个(97%)融合成功,融合引导穿刺额外识别46个(23%)PET阳性淋巴结,其中13/42(31%)为恶性。结论认为该技术可行,融合引导穿刺可增加恶性淋巴结检出数量。

要点

  • 实时超声与FDG-PET/CT图像融合在颈部淋巴结可行,201个PET阳性淋巴结中195个(97%)融合成功。
  • 常规超声引导穿刺的175个淋巴结中,149个(85%)经融合确认FDG-PET阳性,20个为FDG-PET阴性。
  • 融合引导穿刺额外识别46个(23%)PET阳性淋巴结,细胞学恶性13/42(31%)。

核心结论

  • 实时超声与FDG-PET阳性淋巴结图像融合在颈部淋巴结可行,融合引导细针穿刺可增加恶性淋巴结检出数量。

研究设计与样本

  • 前瞻性纳入96例在超声前接受FDG-PET/CT颈部淋巴结分期的患者。
  • 先常规超声引导细针穿刺,再对FDG-PET阳性淋巴结在FDG-PET/CT上标记,使用电磁导航系统PercuNav行实时超声与FDG-PET/CT图像融合。
  • 对已穿刺淋巴结确认PET阳性,并对先前遗漏的PET阳性淋巴结追加融合超声引导细针穿刺。

诊断标准与关键数值

  • 96例中87例(91%)有可疑淋巴结需细针穿刺细胞学。
  • 超声引导细针穿刺共175个淋巴结,细胞学不确定9/175(5%),恶性85/166(51%)。
  • 目标规划201个PET阳性淋巴结,融合成功195/201(97%)。
  • 175个超声引导细针穿刺淋巴结中20个为FDG-PET阴性,149/175(85%)融合超声引导细针穿刺淋巴结确认FDG-PET阳性。
  • 201个PET阳性淋巴结中46个(23%)为额外识别并行融合超声引导细针穿刺,细胞学不确定4/46(9%),恶性13/42(31%)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: New imaging techniques such as hybrid imaging of ultrasound and FDG-PET/CT are available but not yet investigated for node staging. The aim of the study was to evaluate the feasibility and added diagnostic value of real-time image-fused ultrasound-guided fine-needle aspiration with FDG-PET/CT data for node staging.

MATERIALS AND METHODS: Ninety-six patients who were referred for cervical lymph node staging with FDG-PET/CT before ultrasound were prospectively included. After routine ultrasound-guided fine-needle aspiration, all FDG-PET-positive nodes were marked on FDG-PET/CT, and real-time image fusing of ultrasound and FDG-PET/CT was performed using the electromagnetic navigation system PercuNav. Already-punctured nodes were confirmed to be PET-positive, and additional fused-ultrasound-guided fine-needle aspiration was performed in previously missed PET-positive nodes.

RESULTS: Of 96 patients, 87 (91%) patients had suspicious nodes requiring fine-needle aspiration cytology. Ultrasound-guided fine-needle aspiration was performed in 175 nodes. Cytology was inconclusive in 9/175 (5%) nodes, and 85/166 (51%) nodes were malignant. Target planning was performed in 201 PET-positive nodes; 195/201 (97%) of those nodes were fused successfully. Twenty of 175 ultrasound-guided fine-needle aspiration nodes turned out to be FDG-PET-negative, and 149/175 (85%) of the fused ultrasound-guided fine-needle aspiration nodes were confirmed to be FDG-PET-positive. Of 201 PET-positive nodes, 46 (23%) were additionally identified, and fused ultrasound-guided fine-needle aspiration was performed. Cytology was inconclusive in 4/46 nodes (9%), and 13/42 (31%) nodes were malignant.

CONCLUSIONS: Real-time ultrasound image fusion with FDG-PET-positive nodes is feasible in cervical lymph nodes, and fused ultrasound-guided fine-needle aspiration increases the number of malignant nodes detected.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. de Koekkoek-Doll PK, Maas M, Vogel W, et al. Real-Time Ultrasound Image Fusion with FDG-PET/CT to Perform Fused Image-Guided Fine-Needle Aspiration in Neck Nodes: Feasibility and Diagnostic Value. AJNR Am J Neuroradiol. 2021. PMID: 33509917. doi:10.3174/ajnr.A6938

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。